Monday 02/01/2021 1:59:00 PM
Facebook
Google+
ArabFinance: Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) is working on registering ten products in eight new markets, the company’s Managing Director Amr Morsi told Al-Mal in an interview.
According to Morsi, Lebanon, Jordon, Moldova, and some gulf countries are among the list. This is in addition to Pakistan, which Morsi believes is a promising market due to its large population.
Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals. It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others.